Sphera Funds Management Ltd. 13D and 13G filings for Skye Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 5:27 pm Purchase | 2025-03-31 | 13G | Skye Bioscience, Inc. SKYE | Sphera Funds Management Ltd. | 1,476,353 4.770% | 174,835 (+13.43%) | Filing |
| 2024-02-08 09:51 am Purchase | 2024-01-29 | 13G | Skye Bioscience, Inc. SKYE | Sphera Funds Management Ltd. | 1,301,518 5.390% | 1,301,518 (New Position) | Filing |